| Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi CD Van Raamsdonk, V Bezrookove, G Green, J Bauer, L Gaugler, ... Nature 457 (7229), 599-602, 2009 | 1716 | 2009 |
| Dermcidin: a novel human antibiotic peptide secreted by sweat glands B Schittek, R Hipfel, B Sauer, J Bauer, H Kalbacher, S Stevanovic, ... Nature immunology 2 (12), 1133-1137, 2001 | 892 | 2001 |
| T-helper-1-cell cytokines drive cancer into senescence H Braumüller, T Wieder, E Brenner, S Aßmann, M Hahn, M Alkhaled, ... Nature 494 (7437), 361-365, 2013 | 803 | 2013 |
| The prevalence and prognostic value of BRAF mutation in thyroid cancer E Kebebew, J Weng, J Bauer, G Ranvier, OH Clark, QY Duh, D Shibru, ... Annals of surgery 246 (3), 466-471, 2007 | 610 | 2007 |
| Improving melanoma classification by integrating genetic and morphologic features A Viros, J Fridlyand, J Bauer, K Lasithiotakis, C Garbe, D Pinkel, ... PLoS medicine 5 (6), e120, 2008 | 426 | 2008 |
| MC1R germline variants confer risk for BRAF-mutant melanoma MT Landi, J Bauer, RM Pfeiffer, DE Elder, B Hulley, P Minghetti, D Calista, ... Science 313 (5786), 521, 2006 | 391 | 2006 |
| Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations J Bauer, JA Curtin, D Pinkel, BC Bastian Journal of Investigative Dermatology 127 (1), 179-182, 2007 | 386 | 2007 |
| Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data J Bauer, C Garbe Pigment cell research 16 (3), 297-306, 2003 | 338 | 2003 |
| BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary … J Bauer, P Büttner, R Murali, I Okamoto, NA Kolaitis, MT Landi, ... Pigment cell & melanoma research 24 (2), 345-351, 2011 | 264 | 2011 |
| Dose‐dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation J Lutzky, J Bauer, BC Bastian Pigment cell & melanoma research 21 (4), 492-493, 2008 | 242 | 2008 |
| Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool J Bauer, BC Bastian Dermatologic therapy 19 (1), 40-49, 2006 | 219 | 2006 |
| Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases P Radny, UM Caroli, J Bauer, T Paul, C Schlegel, TK Eigentler, B Weide, ... British journal of cancer 89 (9), 1620-1626, 2003 | 197 | 2003 |
| Genetic and morphologic features for melanoma classification SMC Broekaert, R Roy, I Okamoto, J Van Den Oord, J Bauer, C Garbe, ... Pigment cell & melanoma research 23 (6), 763-770, 2010 | 189 | 2010 |
| Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1812 kindergarten children TS Wiecker, H Luther, P Buettner, J Bauer, C Garbe Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 188 | 2003 |
| Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis B Weide, M Elsässer, P Büttner, A Pflugfelder, U Leiter, TK Eigentler, ... British journal of cancer 107 (3), 422-428, 2012 | 179 | 2012 |
| Vemurafenib potently induces endoplasmic reticulum stress–mediated apoptosis in BRAFV600E melanoma cells D Beck, H Niessner, KSM Smalley, K Flaherty, KHT Paraiso, C Busch, ... Science signaling 6 (260), ra7-ra7, 2013 | 172 | 2013 |
| Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma J Bauer, E Kilic, J Vaarwater, BC Bastian, C Garbe, A de Klein British journal of cancer 101 (5), 813-815, 2009 | 155 | 2009 |
| A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal … J Bauer, FA Bahmer, J Wörl, W Neuhuber, G Schuler, M Fartasch Journal of investigative dermatology 116 (2), 313-318, 2001 | 151 | 2001 |
| Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases H Niessner, A Forschner, B Klumpp, JB Honegger, M Witte, A Bornemann, ... Cancer medicine 2 (1), 76-85, 2013 | 148 | 2013 |
| Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy J Bauer, A Blum, U Strohhäcker, C Garbe British Journal of Dermatology 152 (1), 87-92, 2005 | 132 | 2005 |
Boris BastianProfessor of Dermatology and Pathology, University of California, San Francisco在 ucsf.edu 的电子邮件经过验证
